WallStreetZenWallStreetZen

NASDAQ: ALPN
Alpine Immune Sciences Inc Stock Ownership - Who owns Alpine Immune Sciences?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Alpine Immune Sciences Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Xiangmin CuiDirector2022-09-23639,456$7.35
$4.70MBuy
Xiangmin CuiDirector2022-09-231,360,544$7.35
$10.00MBuy
Decheng Capital China Life Sciences Usd Fund Iii LP10% Owner2022-09-23639,456$7.35
$4.70MBuy
Decheng Capital China Life Sciences Usd Fund Iii LP10% Owner2022-09-231,360,544$7.35
$10.00MBuy
Jay VenkatesanDirector2022-07-1520,063$0.45
$9.03kBuy

1 of 1

ALPN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ALPN insiders and whales buy or sell their stock.

ALPN Shareholders

What type of owners hold Alpine Immune Sciences Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Jay Venkatesan14.97%6,871,153$56.07MInsider
Mitchell Gold14.77%6,779,683$55.32MInsider
Decheng Capital China Life Sciences Usd Fund Iii LP14.61%6,708,288$54.74MInsider
James N. Topper10.39%4,770,461$38.93MInsider
Ra Capital Management LP9.58%4,397,368$35.88MInstitution
Orbimed Advisors LLC8.89%4,081,592$33.31MInstitution
James E. Flynn8.13%3,732,412$30.46MInsider
Great Point Partners LLC7.92%3,637,718$29.68MInstitution
Lynx1 Capital Management LP6.81%3,126,173$25.51MInstitution
Frazier Life Sciences Management LP6.50%2,985,757$24.36MInstitution

1 of 3

ALPN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ALPN46.45%53.55%Net Buying
WVE61.36%38.64%Net BuyingNet Selling
STOK36.41%63.59%Net BuyingNet Selling
CNTA67.59%15.15%Net SellingNet Selling
AUTL62.34%0.00%
View Top Biotech Stocks

Alpine Immune Sciences Stock Ownership FAQ

Who owns Alpine Immune Sciences?

Alpine Immune Sciences (NASDAQ: ALPN) is owned by 74.52% institutional shareholders, 85.90% Alpine Immune Sciences insiders, and 0.00% retail investors. Jay Venkatesan is the largest individual Alpine Immune Sciences shareholder, owning 6.87M shares representing 14.97% of the company. Jay Venkatesan's Alpine Immune Sciences shares are currently valued at $55.04M.

If you're new to stock investing, here's how to buy Alpine Immune Sciences stock.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.